Advanced surgical techniques, which utilize flexible endoscopes during laparoscopic
surgery using carbon dioxide intra-luminal insufflation[1], continue to grow in popularity as a result of
clear advantages to patient safety and improved patient outcomes. This has
led to the development of the NEW Olympus UCR CO2 intra-luminal
insufflation unit, which uses carbon dioxide during advanced laparoscopic procedures
to minimize bowel distension, thereby allowing a colonoscopy or upper GI endoscopy
to be performed intra-operatively when combined with the EVIS EXERA II™ universal
platform. This high-definition imaging system provides the flexibility to
perform endoscopic observations and minimally invasive surgery in the O.R.
CO2 insufflation has been proven to be safe and effective,
while speeding the absorption rate by up to 150x when compared to air insufflation.
This allows the surgeons to perform an intra-operative endoscopy prior to, during
or immediately after the procedure to confirm lesions, identify bleeds and check
for anastomotic leaks. As a result, patient outcomes are improved because
endoscopic visualization assists in detecting problems immediately as opposed to
post-operatively and patients experience less pain and discomfort, which is normally
associated with bowel distension caused by air insufflation.
[1]
NORCCAP (Norwegian colorectal cancer prevention): a randomized trial to assess the
safety and efficacy of carbon dioxide versus air insufflation in colonoscopy.Bretthauer
M, Thiis-Evensen E, Huppertz-Hauss G, Gisselsson L, Grotmol T, Skovlund E, Hoff
G.
NORCCAP-Centre, Telemark Central Hospital, Porsgrunn, Norway Department
of Anaesthesiology, Telemark Central Hospital, Porsgrunn, Norway. 9 July 2001.
|
